Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
ZR-75-1
HR+
Luminal
AG1024
IGF1R
RTK
7553.066
uM
inf
inf
0.8384 0.8384 0.0000 0.1034
0.2803
0.9707
BT-474
HER2amp
Luminal
Dactolisib
PI3K
PI3K
12291.155
uM
inf
inf
0.8638 0.8638 0.0000 0.1956
0.2806
0.4532
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12178.135
uM
inf
inf
0.9217 0.9217 0.0000 -0.0119
0.2808
0.5524
MDA-MB-361
HER2amp
Luminal
PD 98059
MEK
MAPK
10999.152
uM
inf
inf
0.7974 0.7974 0.0000 0.0618
0.2809
0.8426
SUM185PE
TNBC
Luminal
PD 98059
MEK
MAPK
12269.152
uM
inf
inf
0.1019 0.1019 0.0000 0.1402
0.2810
0.8791
MDA-MB-361
HER2amp
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7505.016
uM
inf
inf
0.8207 0.8207 0.0000 0.1123
0.2810
1.0721
MDA-MB-415
HR+
Luminal
ICRF-193
TOP2
TOP
10938.151
uM
inf
inf
0.3561 0.3561 0.0000 0.2452
0.2832
1.0747
UACC-893
HER2amp
Luminal
Trametinib
MEK
MAPK
9933.012
uM
inf
inf
0.1298 0.1298 0.0000 0.3783
0.2836
0.4114
HCC1419
HER2amp
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7440.095
uM
inf
inf
0.6165 0.6165 0.0000 0.2930
0.2845
0.5907
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12291.155
uM
inf
inf
0.8808 0.8808 0.0000 -0.0271
-0.2848
0.4532
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12291.155
uM
inf
inf
0.8808 0.8808 0.0000 -0.0271
-0.2848
0.4532
SUM225CWN
HER2amp
Basal A
Chk2 inhibitor II
CHK2
CHK
10579.14
uM
inf
inf
0.6784 0.6784 0.0000 0.0743
0.2850
0.9303
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7816.017
uM
inf
inf
0.9626 0.9626 0.0000 0.1531
0.2853
1.2318
MDA-MB-134-VI
HR+
Luminal
Erlotinib
EGFR
ErbB
7494.09
uM
inf
inf
0.5852 0.5852 0.0000 0.1382
0.2867
1.0823
MDA-MB-436
TNBC
Basal B
Gefitinib
EGFR
ErbB
7902.016
uM
inf
inf
0.6917 0.6917 0.0000 0.0572
0.2876
1.9004
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7475.069
uM
inf
inf
0.9609 0.9609 0.0000 0.0540
0.2883
2.7183
HCC1395
TNBC
Basal B
Purvalanol A
CDK1
CDK
7435.067
uM
inf
inf
0.6392 0.6392 0.0000 0.0374
0.2883
0.7691
HCC2185
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7464.095
uM
inf
inf
0.9059 0.9059 0.0000 -0.0281
-0.2886
0.5464
UACC-812
HER2amp
Luminal
PD184352
MEK
MAPK
10754.146
uM
inf
inf
1.0409 1.0409 0.0000 -0.0246
-0.2891
1.2483
UACC-812
HER2amp
Luminal
PD184352
MEK
MAPK
10754.146
uM
inf
inf
1.0409 1.0409 0.0000 -0.0246
-0.2891
1.2483
SUM102PT
TNBC
Basal B
Trastuzumab
HER2
ErbB
9777.124
uM
inf
inf
0.8331 0.8331 0.0000 0.0175
0.2896
0.6278
SUM225CWN
HER2amp
Basal A
FR180204
ERK1/2
MAPK
12098.161
uM
inf
inf
0.4834 0.4834 0.0000 0.1703
0.2896
1.4196
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
7918.016
uM
inf
inf
0.6825 0.6825 0.0000 0.1161
0.2905
3.1190
HCC2185
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7464.098
uM
inf
inf
0.9208 0.9208 0.0000 0.0740
0.2911
0.6305
SUM185PE
TNBC
Luminal
Glycyl-H-1152
ROCK2
12269.16
uM
inf
inf
0.1892 0.1892 0.0000 0.6667
0.2914
0.6567